Cargando…

Sick sinus syndrome associated with anti-programmed cell death-1

BACKGROUND: Use of anti-programmed cell death-1 (anti-PD-1) has been successful in treating many types of cancers. Despite its promising efficacy, immune-related adverse events are still a major concern. Immune-related cardiotoxicity, which is rare but fatal, has recently become a focus of attention...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chien-Yi, Su, Yu-Wen, Chen, San-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048844/
https://www.ncbi.nlm.nih.gov/pubmed/30012209
http://dx.doi.org/10.1186/s40425-018-0388-9